Fasitibant Uses, Dosage, Side Effects and more
Fasitibant is under investigation in clinical trial NCT02205814 (Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee).
| Trade Name | Fasitibant |
| Generic | Fasitibant |
| Type | |
| Formula | C36H49Cl2N6O6S |
| Weight | Average: 764.78 Monoisotopic: 763.2805863 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
